Intellect Neurosciences, Inc.

Intellect Neurosciences, Inc.

Sector: Pharmaceutical Preparations Region: NJ, United States

: | OTC Markets: ILNS

Similar to: Shire PLC, Sanofi, BioGaia AB

Intellect Neurosciences, Inc. is a biopharmaceutical company that is engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of neurodegenerative conditions, collectively known as proteinopathies, which include Alzheimer's, Parkinson's and Huntington disease. The company was founded by Daniel G. Chain on April 25, 2005 and is headquartered in New York, NY.

News & Analysis

You may also be interested in: